The United Kingdom became the first nation to inoculate people with the Oxford/AstraZeneca coronavirus vaccine outside of trials on Monday, with the country’s health secretary hailing the day as a “real pivotal moment.”
Doses of the vaccine, approved by UK regulators on December 30, will initially be delivered at “a small number of hospitals for the first few days for surveillance purposes,” before the bulk of doses arrives at medical practices later in the week, said England’s National Health Service (NHS).
Totally plc (LON:TLY) addresses the challenges of increased demand on healthcare services by delivering high-quality planned, urgent and insourcing healthcare across the UK and Ireland.